REGN - Regeneron Pharmaceuticals Inc. (REGN) TD Cowen 44th Annual Health Care Conference Call Transcript
2024-03-06 15:33:05 ET
Regeneron Pharmaceuticals, Inc. (REGN)
TD Cowen 44th Annual Health Care Conference
March 06, 2024 11:10 AM ET
Company Participants
Marion McCourt - EVP of Commercial
Ryan Crowe - SVP and Head of IR
Conference Call Participants
Tyler Van Buren - TD Cowen
Presentation
Tyler Van Buren
All right. Good morning, everyone. Thanks again for being here at the TD Cowen 44th Annual Healthcare Conference Day 3. My name is Tyler Van Buren, your senior biotech analyst at TD Cowen.
For the next session, we have a fireside chat with Regeneron. It's a privilege to have Regeneron here. And I would like to introduce Marion McCourt, Executive Vice President of Commercial; and Ryan Crowe, Senior Vice President and Head of Investor Relations.
Marion, Ryan, thank you very much for being here.
Ryan Crowe
Thank you, Tyler.
Tyler Van Buren
Before I get started for those in the audience, if you have any questions during the chat, go ahead and raise your hand, and we'll do our best to get them answered.
But before I get into it, Ryan, I believe you have a few things to say?
Ryan Crowe
I have to go through our forward-looking statement disclaimers. Just give me a moment to read this. I'd like to remind you that our remarks made today may include forward-looking statements about Regeneron. Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in such statements....
Regeneron Pharmaceuticals, Inc. (REGN) TD Cowen 44th Annual Health Care Conference Call Transcript